文献速递中药与中成药合理使用

血脂灵片治疗高脂血症的质量标志物确定

Determination of quality markers of Xuezhiling tablet for hyperlipidemia treatment.
PubMed 文献 · Phytomedicine · 2018-03-15

该研究通过整合降脂药效、代谢组学、含量测定和药代动力学调查,确定血脂灵片(XZL)的质量标志物(Q-marker)。高脂饮食诱导大鼠高脂血症模型,XZL可降低TG、TC和LDL-C水平并改变代谢模式。在制剂和给药血浆中鉴定并测定了7种成分,其中SHJ、obtusinfolin、THSG、rubrofusarin gentiobioside和aurantio-obtusin在制剂中含量较高且体内暴露更高,适合作为质量标志物。

要点

  • XZL可降低高脂饮食大鼠的TG、TC和LDL-C水平。
  • 在制剂和血浆中鉴定出7种主要活性成分。
  • SHJ、obtusinfolin、THSG、rubrofusarin gentiobioside和aurantio-obtusin可作为Q-marker。

核心结论

  • SHJ、obtusinfolin、THSG、rubrofusarin gentiobioside和aurantio-obtusin在制剂中含量较高且体内暴露更高,适合作为XZL的质量标志物以保证药用质量和临床疗效。

研究设计与样本

  • 研究采用高脂饮食诱导的大鼠高脂血症模型,整合降脂药效、代谢组学、含量测定和药代动力学研究。

主要发现

  • XZL通过改变代谢模式降低TG、TC和LDL-C水平。
  • 在XZL制剂和高脂血症大鼠给药血浆中鉴定并测定了THSG、SHJ、cassiaside、rubrofusarin gentiobioside、aurantio-obtusin、chryso-obtusin和obtusinfolin。

关键数值与推荐

  • SHJ、obtusinfolin、THSG、rubrofusarin gentiobioside和aurantio-obtusin被确定为XZL的Q-markers。

临床怎么用

  • 确定的Q-markers可用于XZL的质量控制,确保其治疗高脂血症的临床有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The massive number of ingredients in traditional Chinese medicines (TCMs) makes quality control very difficult. The concept of quality markers (Q-marker) was recently proposed to evaluate the quality of TCMs. Xuezhiling tablets (XZL) are widely used for the treatment of hyperlipidemia in China owing to its noticeable effectiveness and mild adverse effects, but there are no proper Q-markers for this Chinese patent medicine. PURPOSE: The aim of the present study was to determine the Q-markers of XZL against hyperlipidemia through an integration of investigations on its lipid-lowering effect, metabolomics, content determination and pharmacokinetics. METHODS: XZL was prepared in accordance with the method described in the Chinese pharmacopoeia (Ch.P.). Hyperlipidemia was induced in rats through the administration of a high-fat diet (HFD). The hypolipidemic effect of XZL was investigated through the detection of the blood levels of total glyceride (TG), total cholesterol (TC), and low density lipoprotein cholesterol (LDL-C). A metabolomics study was conducted to analyze the overall effects of XZL on the regulation of lipid metabolism. The main bioactive compounds of XZL were identified and determined in the XZL preparation and the medicated plasma of hyperlipidemic rats. RESULTS: XZL lowered the levels of TG, TC, and LDL-C through alterations of metabolic patterns. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucopyranoside (THSG), chrysophanol-1-O-β-glucopyranosyl-(1→3)-O-β-D-glucopyranosy1-(1→6)-O-β-D-glucopyranosyl-(1→6)-O-β-D-glucopyranoside (SHJ), cassiaside, rubrofusarin gentiobioside, aurantio-obtusin, chryso-obtusin, and obtusinfolin were identified and determined both in the preparation and the blood of hyperlipidemic rats. CONCLUSION: SHJ, obtusinfolin, THSG, rubrofusarin gentiobioside, and aurantio-obtusin, which are more abundant in the preparation, leading to greater exposure in vivo, were suitable Q-markers to guarantee the medicinal quality of XZL and ensure the clinical effectiveness on hyperlipidemia.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Nie C, Zhang F, Ma X, et al. Determination of quality markers of Xuezhiling tablet for hyperlipidemia treatment. Phytomedicine. 2018. PMID: 29631806. doi:10.1016/j.phymed.2018.03.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。